Document Detail

BCR-ABL negative myeloproliferative neoplasia: A review of involved molecular mechanisms.
MedLine Citation:
PMID:  25196073     Owner:  NLM     Status:  Publisher    
The clonal bone marrow stem cell disorders essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF) belong to the group of Philadelphia chromosome negative myeloproliferative neoplasia (Ph- MPN). In 2005 the JAK2V617F mutation was discovered which has generated more insight in the pathogenetic mechanism of the MPNs. More mutations have been detected in MPN patients since. However, the underlying cause of MPN has not been discovered so far. The mechanism of increased angiogenesis in MPNs and the development of fibrosis in the bone marrow in PMF patients and in some ET and PV patients is still not known. This review will focus on the most important molecular pathogenetic mechanisms in MPN patients.
Suzanne M Koopmans; Harry C Schouten; Ariënne M W van Marion
Related Documents :
1097173 - The relationship between patient demographic characteristics and psychiatric rehabilita...
2723093 - Differences in the symptom check list-90 profiles of black and white methadone patients.
2942773 - Diabetic thoracic radiculopathy: electrodiagnostic study.
Publication Detail:
Type:  REVIEW     Date:  2014-9-3
Journal Detail:
Title:  Histology and histopathology     Volume:  -     ISSN:  1699-5848     ISO Abbreviation:  Histol. Histopathol.     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8609357     Medline TA:  Histol Histopathol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Determining the major Bt refuge crops for cotton bollworm in North China.
Next Document:  Pitfalls in microcystin extraction and recovery from human blood serum.